Category:MARK K. SCHLEGEL of LEXINGTON MA (US)

MARK K. SCHLEGEL of LEXINGTON MA (US)

Executive Summary

MARK K. SCHLEGEL of LEXINGTON MA (US) is an inventor who has filed 4 patents. Their primary areas of innovation include MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media (4 patents), Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants (3 patents), of the backbone (3 patents), and they have worked with companies such as ALNYLAM PHARMACEUTICALS, INC. (4 patents). Their most frequent collaborators include (4 collaborations), (4 collaborations), (3 collaborations).

Patent Filing Activity

File:MARK K. SCHLEGEL of LEXINGTON MA (US) Monthly Patent Applications.png

Technology Areas

File:MARK K. SCHLEGEL of LEXINGTON MA (US) Top Technology Areas.png

List of Technology Areas

• C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 4 patents
• C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 3 patents
• C12N2310/3125 (of the backbone): 3 patents
• C12N2310/315 (of the backbone): 3 patents
• C12N2310/321 (2'-O-R Modification): 3 patents
• C12N2310/351 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
• A61K31/713 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 patents
• C12N2310/322 (2'-R Modification): 2 patents
• C12N15/1137 ({against enzymes (viral enzymes): 1 patents
• C12Y402/01001 (ENZYMES): 1 patents
• C12N2310/3515 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/313 (of the backbone): 1 patents

Companies

File:MARK K. SCHLEGEL of LEXINGTON MA (US) Top Companies.png

List of Companies

• ALNYLAM PHARMACEUTICALS, INC.: 4 patents

Collaborators

• JEFFREY ZUBER of SOMERVILLE MA (US) (4 collaborations)
• ADAM CASTORENO of FRAMINGHAM MA (US) (4 collaborations)
• JAMES D. MCININCH of BURLINGTON MA (US) (3 collaborations)
• LUCAS BONDURANT of BROOKLINE MA (US) (2 collaborations)
• DHAVAL OZA of BOSTON MA (US) (2 collaborations)
• LUCAS WARD of CAMBRIDGE MA (US) (1 collaborations)
• AIMEE DEATON of SOMERVILLE MA (US) (1 collaborations)